M16-312
ClinicalTrials.gov NCT03035279
Research payments
$909,348
Through program year 2020, $909,348 in research payments was reported against M16-312, across 86 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03035279
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $136,626 | 24 |
| 2019 | Research | $772,722 | 62 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Johanna Bendell Nashville, TN Named on 27 payments
- John Krauss Ann Arbor, MI Named on 9 payments
- Andrea Cercek New York, NY Named on 8 payments
- Katrina Pedersen Saint Louis, MO Named on 7 payments
- Joel Hecht Los Angeles, CA Named on 7 payments
- Joseph Beck Fayetteville, AR Named on 6 payments
- John Powderly Huntersville, NC Named on 5 payments
- Amit Mahipal Rochester, MN Named on 5 payments
- Susanna Ulahannan Ponca City, OK Named on 5 payments
- Alexis Leal Aurora, CO Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.